Covishield vaccine induces robust immune responses in Bangladeshi adults
IJID Regions(2022)
Abstract
•All participants became seropositive 2 months after receipt of the second dose of vaccine.•Comparable antibody responses were observed in both males and females.•Participants with previous severe acute respiratory syndrome coronavirus-2 infection showed a robust antibody response.•Similar antibody responses were observed in participants with and without comorbidities.
MoreTranslated text
Key words
Covishield,Seropositive,Antibodies,Bangladesh,Comorbidity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined